Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$40.46 - $43.52 $2.22 Million - $2.38 Million
-54,759 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$39.4 - $42.7 $30,535 - $33,092
775 Added 1.44%
54,759 $2.19 Million
Q1 2019

May 10, 2019

BUY
$38.57 - $42.69 $25,186 - $27,876
653 Added 1.22%
53,984 $2.26 Million
Q4 2018

Feb 05, 2019

BUY
$37.8 - $42.69 $6,010 - $6,787
159 Added 0.3%
53,331 $2.04 Million
Q3 2018

Nov 08, 2018

BUY
$39.75 - $42.69 $6,002 - $6,446
151 Added 0.28%
53,172 $2.14 Million
Q2 2018

Aug 09, 2018

BUY
$39.61 - $42.76 $7,803 - $8,423
197 Added 0.37%
53,021 $2.14 Million
Q1 2018

May 14, 2018

BUY
$36.18 - $40.15 $1.91 Million - $2.12 Million
52,824 New
52,824 $2.06 Million
Q4 2017

Jan 29, 2018

SELL
$35.34 - $41.9 $1.82 Million - $2.16 Million
-51,453 Closed
0 $0
Q3 2017

Oct 27, 2017

BUY
$39.44 - $41.55 $2.03 Million - $2.14 Million
51,453
51,453 $2.09 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.